Brechbuhl et al. analysed the presence of CD146‐positive and CD146‐negative CAFs in ER+ breast cancer patients' tissues and found that CD146‐negative CAFs reduce ER expression and tumour cell sensitivity to oestrogen and tamoxifen sensitivity in ER breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.